About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 55 record(s)
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Req # A2023-0043340
Any correspondence with the Pathways Alliance, Cenovus, Suncor, the Canadian Energy Centre, the Candian Association of Petroleum Producers, or ConocoPhillips — or their marketing agencies of record, Juniper Park/TBWA, DDB, Carmichael Lynch, or other representatives — regarding hydrogen. Date range: 2021-01-01 to present.Organization: Invest in Canada
December 2023
Req # A2023-0043338
Any meeting notes or briefing notes regarding meetings with the Pathways Alliance, Cenovus, Suncor, the Canadian Energy Centre, the Candian Association of Petroleum Producers, or ConocoPhillips — or their marketing agencies of record, Juniper Park/TBWA, DDB, Carmichael Lynch, or other representatives — regarding hydrogen. Date range: 2021-01-01 to present.Organization: Invest in Canada
December 2023
Req # A2023-0043336
Any results reports, postmortems, or audits regarding advertising in the Financial Times or other media outlets that include hydrogen as the subject matter. Date range: 2021-01-01 to present.Organization: Invest in Canada
December 2023
Req # A2023-0043332
Any invoices, expense reports, contracts, or other documentation regarding advertising in the Financial Times or other media outlets that include hydrogen as the subject matter. Date range: 2021-01-01 to present.Organization: Invest in Canada
December 2023
Req # A-2023-0043030
Records showing the total amount spent on office equipment to facilitate employees working from home in the calendar years of 2020, 2021 and 2022.Organization: Invest in Canada
December 2023
Req # A-2023-0043028
Records showing the total cost of office furniture purchased during the calendar years of 2020, 2021 and 2022.Organization: Invest in Canada
December 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023